BETHANIE MURASKI: Open Payments
NPI 1952960643 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 65 payments from 18 companies in 2025. Trend: 2023 $2,859 · 2024 $2,694 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $333 |
| Novo Nordisk Inc | 10 | $167 |
| Teva Pharmaceuticals USA, Inc. | 5 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Almatica Pharma LLC | 3 | $63 |
| PFIZER INC. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: VRAYLAR, Ozempic, UBRELVY, AJOVY, CAPLYTA, TRINTELLIX, CREON, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
